![]() |
Name |
7-O-acetylemindole SB
|
Molecular Formula | C30H41NO2 | |
IUPAC Name* |
[(1S,12S,15R,16S,17S,20S)-1,16,20-trimethyl-16-(4-methylpent-3-enyl)-3-azapentacyclo[10.8.0.02,10.04,9.015,20]icosa-2(10),4,6,8-tetraen-17-yl] acetate
|
|
SMILES |
CC(=CCC[C@]1([C@@H]2CC[C@H]3CC4=C([C@@]3([C@]2(CC[C@@H]1OC(=O)C)C)C)NC5=CC=CC=C45)C)C
|
|
InChI |
InChI=1S/C30H41NO2/c1-19(2)10-9-16-28(4)25-14-13-21-18-23-22-11-7-8-12-24(22)31-27(23)30(21,6)29(25,5)17-15-26(28)33-20(3)32/h7-8,10-12,21,25-26,31H,9,13-18H2,1-6H3/t21-,25-,26-,28-,29-,30+/m0/s1
|
|
InChIKey |
DSXLGNIJDSGMKC-DOAVDDFWSA-N
|
|
Synonyms |
7-O-acetylemindole SB
|
|
CAS | NA | |
PubChem CID | 139590471 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 447.7 | ALogp: | 8.2 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 42.1 | Aromatic Rings: | 5 |
Heavy Atoms: | 33 | QED Weighted: | 0.385 |
Caco-2 Permeability: | -4.938 | MDCK Permeability: | 0.00002240 |
Pgp-inhibitor: | 0.998 | Pgp-substrate: | 0.01 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.985 |
30% Bioavailability (F30%): | 0.945 |
Blood-Brain-Barrier Penetration (BBB): | 0.055 | Plasma Protein Binding (PPB): | 95.14% |
Volume Distribution (VD): | 3.896 | Fu: | 3.25% |
CYP1A2-inhibitor: | 0.538 | CYP1A2-substrate: | 0.16 |
CYP2C19-inhibitor: | 0.287 | CYP2C19-substrate: | 0.866 |
CYP2C9-inhibitor: | 0.362 | CYP2C9-substrate: | 0.529 |
CYP2D6-inhibitor: | 0.903 | CYP2D6-substrate: | 0.222 |
CYP3A4-inhibitor: | 0.91 | CYP3A4-substrate: | 0.652 |
Clearance (CL): | 7.873 | Half-life (T1/2): | 0.024 |
hERG Blockers: | 0.95 | Human Hepatotoxicity (H-HT): | 0.554 |
Drug-inuced Liver Injury (DILI): | 0.466 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.599 | Maximum Recommended Daily Dose: | 0.874 |
Skin Sensitization: | 0.937 | Carcinogencity: | 0.354 |
Eye Corrosion: | 0.014 | Eye Irritation: | 0.065 |
Respiratory Toxicity: | 0.969 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001931 | ![]() |
0.796 | D0X7XG | ![]() |
0.308 | ||
ENC005883 | ![]() |
0.609 | D0H4JM | ![]() |
0.295 | ||
ENC002707 | ![]() |
0.589 | D0K0KH | ![]() |
0.275 | ||
ENC003932 | ![]() |
0.587 | D01JGV | ![]() |
0.275 | ||
ENC000857 | ![]() |
0.530 | D0U7GP | ![]() |
0.275 | ||
ENC004710 | ![]() |
0.521 | D01HTL | ![]() |
0.273 | ||
ENC003933 | ![]() |
0.512 | D09QVV | ![]() |
0.268 | ||
ENC005405 | ![]() |
0.508 | D0W9MM | ![]() |
0.266 | ||
ENC003928 | ![]() |
0.484 | D0OT9S | ![]() |
0.261 | ||
ENC002279 | ![]() |
0.467 | D06CNP | ![]() |
0.259 |